{"id":"https://openalex.org/W1702310275","doi":null,"title":"Effects of ranibizumab on TGF-\u03b21 and TGF-\u03b22 production by human Tenon's fibroblasts: An in vitro study.","display_name":"Effects of ranibizumab on TGF-\u03b21 and TGF-\u03b22 production by human Tenon's fibroblasts: An in vitro study.","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1702310275","mag":"1702310275","pmid":"https://pubmed.ncbi.nlm.nih.gov/26539031","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4605752"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4605752","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Vis","raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W1702310275"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024554869","display_name":"Siti Munirah Md Noh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siti Munirah Md Noh","raw_affiliation_strings":["Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034347521","display_name":"Siti Hamimah Sheikh Abdul Kadir","orcid":"https://orcid.org/0000-0002-1671-4839","observed_orcids":["https://orcid.org/0000-0002-1671-4839"]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siti H Sheikh Abdul Kadir","raw_affiliation_strings":["Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110843028","display_name":"Jonathan Guy Crowston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I4210105949","display_name":"Centre for Eye Research Australia","ror":"https://ror.org/01sqdef20","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210105949"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan G Crowston","raw_affiliation_strings":["Centre for Eye Research Australia, the University Of Melbourne, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Eye Research Australia, the University Of Melbourne, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I4210105949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050294080","display_name":"Visvaraja Subrayan","orcid":"https://orcid.org/0000-0002-6884-2779","observed_orcids":["https://orcid.org/0000-0002-6884-2779"]},"institutions":[{"id":"https://openalex.org/I33849332","display_name":"University of Malaya","ror":"https://ror.org/00rzspn62","country_code":"MY","type":"education","lineage":["https://openalex.org/I33849332"]}],"countries":["MY"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Visvaraja Subrayan","raw_affiliation_strings":["Department of Ophthalmology, Faculty of Medicine, University of Malaya, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Faculty of Medicine, University of Malaya, Malaysia","institution_ids":["https://openalex.org/I33849332"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109256363","display_name":"Sushil Kumar Vasudevan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sushil Vasudevan","raw_affiliation_strings":["Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Brain and Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM) Shah Alam, Selangor, Malaysia","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0854,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74179367,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"21","issue":null,"first_page":"1191","last_page":"1200"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":1.0},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.8949999809265137},{"id":"https://openalex.org/keywords/tgf-beta2","display_name":"TGF-beta2","score":1.0},{"id":"https://openalex.org/keywords/trabeculectomy","display_name":"trabeculectomy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/bleb-scarring","display_name":"bleb scarring","score":0.8560000061988831},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/antifibrotic-agents","display_name":"antifibrotic agents","score":0.9269999861717224},{"id":"https://openalex.org/keywords/fibroblast-proliferation","display_name":"fibroblast proliferation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.8230000138282776},{"id":"https://openalex.org/keywords/wound-healing","display_name":"wound healing","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.8900671005249023},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.6915762424468994},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.6001494526863098},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5668296217918396},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.5109094977378845},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.47189316153526306},{"id":"https://openalex.org/C2777824320","wikidata":"https://www.wikidata.org/wiki/Q3177088","display_name":"Trabeculectomy","level":3,"score":0.4466349482536316},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.43080881237983704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4291403591632843},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4053586423397064},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37206971645355225},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.33933335542678833},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32828083634376526},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.30435919761657715},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27674973011016846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2485537827014923},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13229772448539734},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12963679432868958},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.11570131778717041},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.09409508109092712},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.057370930910110474},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002921","descriptor_name":"Cicatrix","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002921","descriptor_name":"Cicatrix","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002921","descriptor_name":"Cicatrix","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014130","descriptor_name":"Trabeculectomy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053781","descriptor_name":"Transforming Growth Factor beta2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D053781","descriptor_name":"Transforming Growth Factor beta2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058475","descriptor_name":"Tenon Capsule","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D058475","descriptor_name":"Tenon Capsule","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D058475","descriptor_name":"Tenon Capsule","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061251","descriptor_name":"Primary Cell Culture","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:4605752","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Vis","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:3607333","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4605752","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26539031","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26539031","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular vision","raw_type":"Journal Article"},{"id":"mag:1702310275","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26539031","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4605752","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4605752/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Vis","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321784","display_name":"Kementerian Sains, Teknologi dan Inovasi","ror":"https://ror.org/012s3r374"},{"id":"https://openalex.org/F4320321992","display_name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","ror":"https://ror.org/050zdnc69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1702310275.pdf","grobid_xml":"https://content.openalex.org/works/W1702310275.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W90704299","https://openalex.org/W1502290542","https://openalex.org/W1524114372","https://openalex.org/W1594821370","https://openalex.org/W1604878774","https://openalex.org/W1702338498","https://openalex.org/W1858196375","https://openalex.org/W1970142574","https://openalex.org/W1987087672","https://openalex.org/W1997419670","https://openalex.org/W2004845166","https://openalex.org/W2007624423","https://openalex.org/W2017732602","https://openalex.org/W2017909699","https://openalex.org/W2018534552","https://openalex.org/W2019061836","https://openalex.org/W2023874692","https://openalex.org/W2025567573","https://openalex.org/W2034126310","https://openalex.org/W2035353185","https://openalex.org/W2035468975","https://openalex.org/W2036232712","https://openalex.org/W2036984238","https://openalex.org/W2037623038","https://openalex.org/W2044270182","https://openalex.org/W2045247659","https://openalex.org/W2045258419","https://openalex.org/W2047047519","https://openalex.org/W2058775052","https://openalex.org/W2062254714","https://openalex.org/W2071787763","https://openalex.org/W2077129920","https://openalex.org/W2086586378","https://openalex.org/W2091042111","https://openalex.org/W2123550509","https://openalex.org/W2124415048","https://openalex.org/W2157769714","https://openalex.org/W2162567193","https://openalex.org/W2169055208","https://openalex.org/W2318475202","https://openalex.org/W2417698919","https://openalex.org/W2471444383","https://openalex.org/W4322388198"],"related_works":["https://openalex.org/W1993765848","https://openalex.org/W2896967092","https://openalex.org/W3202455255","https://openalex.org/W2522106976","https://openalex.org/W2017909699","https://openalex.org/W4367052003","https://openalex.org/W2949886900","https://openalex.org/W4236307025","https://openalex.org/W3204525585","https://openalex.org/W1990915357"],"abstract_inverted_index":{"PURPOSE:":[0],"Inhibiting":[1],"exaggerated":[2],"wound":[3],"healing":[4],"responses,":[5],"which":[6],"are":[7],"primarily":[8],"mediated":[9],"by":[10,88,198],"human":[11],"Tenon's":[12],"fibroblast":[13],"(HTF)":[14],"migration":[15],"and":[16,82,98,122,127,131,140,143,153,194],"proliferation,":[17],"has":[18,33],"become":[19],"the":[20,61,73,188,219,225,253],"major":[21],"determining":[22],"factor":[23,31,80,85],"for":[24,42,119,138,185],"a":[25,38,177,235,242,264],"successful":[26],"trabeculectomy.":[27,46],"Antivascular":[28],"endothelial":[29],"growth":[30,79,84],"(anti-VEGF)":[32],"showed":[34],"promising":[35],"results":[36],"as":[37,234],"potential":[39,236],"antifibrotic":[40,250],"candidate":[41],"use":[43],"concurrently":[44],"in":[45,125,180,216],"Preliminary":[47],"cohort":[48],"studies":[49],"have":[50],"revealed":[51],"improved":[52],"bleb":[53],"morphology":[54],"following":[55],"trabeculectomy":[56],"augmented":[57],"with":[58,248],"ranibizumab.":[59],"However,":[60,187],"effects":[62,74],"on":[63,77,95],"HTFs":[64,205],"remain":[65],"unclear.":[66],"This":[67],"study":[68],"was":[69,101,196],"conducted":[70],"to":[71,114,206,223],"understand":[72],"of":[75,93,164,192,204,210,228,255,257,263],"ranibizumab":[76,94,165,211,233,258],"transforming":[78,83],"(TGF)-\u03b21":[81],"(TGF)-\u03b22":[86],"expression":[87],"HTFs.":[89],"METHODS:":[90],"The":[91],"effect":[92],"HTF":[96],"proliferation":[97],"cell":[99,132,168,214],"viability":[100,215],"determined":[102],"using":[103,146],"3-(4,5-dimethylthiazone-2-yl)-2,5-diphenyl":[104],"tetrazolium":[105],"(MTT)":[106],"assay.":[107],"Ranibizumab":[108,175],"at":[109],"concentrations":[110],"ranging":[111],"from":[112,134],"0.01":[113],"0.5":[115,162],"mg/ml":[116,163],"were":[117,136],"administered":[118],"24,":[120],"48,":[121],"72":[123],"h":[124],"serum":[126],"serum-free":[128,171],"conditions.":[129],"Supernatants":[130],"lysates":[133],"samples":[135],"assessed":[137],"TGF-\u03b21":[139,181,193],"TGF-\u03b22":[141,195],"mRNA":[142],"protein":[144,190],"levels":[145],"quantitative":[147],"real-time":[148],"polymerase":[149],"chain":[150],"reaction":[151],"(qRT-PCR)":[152],"enzyme-linked":[154],"immunosorbent":[155],"assay":[156],"(ELISA).":[157],"RESULTS:":[158],"At":[159],"48":[160],"h,":[161],"significantly":[166,212],"induced":[167],"death":[169],"under":[170],"culture":[172],"conditions":[173],"(p<0.05).":[174],"caused":[176],"significant":[178],"reduction":[179],"mRNA,":[182],"but":[183],"not":[184],"TGF-\u03b22.":[186],"total":[189],"production":[191,227],"unaffected":[197],"this":[199],"anti-VEGF":[200],"treatment.":[201],"CONCLUSIONS:":[202],"Exposure":[203],"an":[207,260],"intravitreal":[208],"dose":[209],"suppresses":[213],"vitro;":[217],"however,":[218],"application":[220],"seemed":[221],"unable":[222],"affect":[224],"ultimate":[226],"TGF-\u03b2.":[229],"Therefore,":[230],"we":[231],"highlighted":[232],"antiscarring":[237],"agent":[238],"that":[239],"acts":[240],"via":[241],"different":[243],"mechanism":[244,254],"when":[245],"used":[246],"synergistically":[247],"another":[249],"agent.":[251],"Understanding":[252],"actions":[256],"offers":[259],"additional":[261],"view":[262],"possible":[265],"new":[266],"rational":[267],"therapeutic":[268],"strategy.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1702310275","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
